Image For Activity Cover
Pharmacological Management of Diabetes
Module Description
In this module, you will learn how to apply knowledge of patient-based factors (such as cardiovascular and/or renal status, obesity, organ system dysfunction, and age) to determine the appropriate drug therapy for individuals with diabetes.
Learning Objectives
At the end of this module, participants will be able to:
  1. Recall appropriate A1C goals for people with diabetes in the context of their comorbidities and other health factors.
  2. Recognize the goals of pharmacological therapy for people with diabetes.
  3. Identify the various elements of the decision cycle for patient-centered glycemic management in diabetes.
  4. Select the appropriate pharmacologic agent in a clinical scenario.
Module Faculty

Nuha El Sayed, MD, MMSc

Dr. El Sayed is the Vice President of Healthcare Improvement, American Diabetes Association.

She oversees the development of the ADA's Standards of Medical Care and consensus statements, serves as chair of the Professional Practice Committee, and heads the professional education and accreditation. She also leads the quality improvement and international programs for the American Diabetes Association.

Dr. El Sayed is an endocrinologist and faculty at Harvard Medical School. Her clinical expertise includes general diabetes, diabetes prevention, lifestyle medicine, and diabetes technology. She has over a decade of experience in combined diabetes and quality improvement and training programs nationally and internationally. Her programs include training healthcare workforces, professionals, trainees, and students across the US and the globe to support the improvement of diabetes care.


Alissa R. Segal, PharmD, RPh, CDCES, CDTC, FCCP

Dr. Segal is a Professor of Pharmacy Practice at the Massachusetts College of Pharmacy & Health Sciences and the clinical pharmacist at the Joslin Diabetes Center, Boston, MA. Dr. Segal completed her Doctor of Pharmacy at Drake University and post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina.

After she spent several years of teaching, practice, and research at the University of New Mexico, Dr. Segal joined MCPHS in 2007, and established clinical pharmacy services at the Joslin Diabetes Center. Her research focus on the care of adults with diabetes has led to numerous publications on topics, including: diabetes in older adults and concentrated insulin, pharmacotherapy guidelines for patients with type 2 diabetes, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes.

Dr. Segal is the first clinical pharmacist at the Joslin Diabetes Center, where she assists in provider, staff, and continuing professional education, patient education and care, and clinical trials, as well as serves on the institutional review board for human studies and guideline committees. Recently, she’s expanded to developing education and training for the IDF and ADA, as well as the Ministry of Health of the Kingdom of Saudi Arabia. Dr. Segal is also the Program Director of the Doctor of Pharmacy Honors Program at the MCPHS School of Pharmacy in Boston, as well as an active member of the Endocrine Practice and Research Network of ACCP, a fellow of ACCP, and the Diabetes & Cardiovascular Disease and Health Care Delivery & Quality Improvement interest groups and the Women’s Interprofessional Network of the American Diabetes Association. 

Course Support
If you have questions about this course, please email .
Availability: On-Demand
Expires on Dec 31, 2022
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ACPE Credit
1 ANCC Credit
1 AAPA Credit
1 CDR Credit
1 COP Credit
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright 2021. All rights reserved.
Powered By